WHAT DO WE KNOW ABOUT NEUROGENIC BOWEL DYSFUNCTION?

被引:0
|
作者
Castro Zocchi, M. Riat [1 ]
Perez Fernandez, T. [1 ]
Santander Vaquero, C. [1 ]
机构
[1] Hosp Univ La Princesa, Serv Aparato Digest, Madrid, Spain
来源
REVISTA CASTELLANA DE GASTROENTEROLOGIA | 2021年 / 36卷 / 04期
关键词
neurogenic bowel dysfunction; constipation; faecal incontinence; spinal cord injury; multiple sclerosis; Parkinson's disease; SPINAL-CORD-INJURY; TRANSANAL IRRIGATION; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; FECAL INCONTINENCE; MANAGEMENT; CONSTIPATION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Central neurological diseases such as spinal cord injury, multiple sclerosis and Parkinson's disease are highly prevalent. Neurogenic bowel dysfunction symptoms (mainly constipation and incontinence) in these patients are very common and have a major negative impact on quality of life. In neurogenic bowel dysfunction patients with spinal cord injury and multiple sclerosis, we can identify two different clinical syndromes depending on the level and extent of the lesion. In supraconal (above the conus medularis) injuries there is an upper motor neuron syndrome with hypertonia and hyperreflexia of the colon and rectum. In injuries involving the conus medularis or the cauda equina a lower motor neuron syndrome occurs, associating hypotonia and areflexia of the colon and rectum. In Parkinson's disease constipation is caused by dystonia of the external anal sphincter and loss of dopaminergic neurons within the enteric nervous system. It is important to perform adequate assessment of the patient prior to treatment, including previous gastrointestinal diseases, proper anamnesis, physical examination and functional evaluation. A step-wise approach of gradually escalating degree of invasiveness is the preferred management strategy for neurogenic bowel disease. Initial management is based on bowel routine, dietary modifications and use of laxatives. In non-responders transanal irrigation may be a suitable approach. Finally, in patients that are refractory to all available treatments, surgical formation of a definitive stoma must be considered.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 50 条
  • [41] Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)
    Previnaire, J. G.
    Soler, J. M.
    Bordji, H.
    Fiolet, M. C.
    Navaux, M. A.
    Mortier, P. E.
    PROGRES EN UROLOGIE, 2016, 26 (10): : 573 - 581
  • [42] Soft skills, do we know what we are talking about?
    Isabel Marin-Zapata, Sara
    Pablo Roman-Calderon, Juan
    Robledo-Ardila, Cristina
    Alejandra Jaramillo-Serna, Maria
    REVIEW OF MANAGERIAL SCIENCE, 2022, 16 (04) : 969 - 1000
  • [43] Exercise Intervention Research on Persons with Disabilities What We Know and Where We Need to Go
    Rimmer, James H.
    Chen, Ming-De
    McCubbin, Jeffrey A.
    Drum, Charles
    Peterson, Jana
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2010, 89 (03) : 249 - 263
  • [44] Malignant Priapism-What Do We Know About It?
    Marcu, Dragos
    Iorga, Lucian
    Mischianu, Dan
    Bacalbasa, Nicolae
    Balescu, Irina
    Bratu, Ovidiu
    IN VIVO, 2020, 34 (05): : 2225 - 2232
  • [45] What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
    Lacroix, Clemence
    Alleman-Brimault, Isabelle
    Zalta, Arnaud
    Rouby, Frank
    Casse-Perrot, Catherine
    Jouve, Elisabeth
    Attolini, Laurence
    Guilhaumou, Romain
    Micallef, Joelle
    Blin, Olivier
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] What Do We Know About How to Treat Tuberculosis?
    Marais, Ben J.
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN VIII, 2011, 719 : 171 - 184
  • [47] What do we know about the International Organization for Migration?
    Pecoud, Antoine
    JOURNAL OF ETHNIC AND MIGRATION STUDIES, 2018, 44 (10) : 1621 - 1638
  • [48] What do we know about prescribing spironolactone for acne?
    Santer, Miriam
    Layton, Alison
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [49] Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
    Alkhawajah, Mona M.
    Caminero, Ana B.
    Freeman, Hugh J.
    Oger, Joel J. F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (03) : 259 - 265
  • [50] Benign anorectal disease in children: What do we know?
    Dimopoulou, Konstantina
    Dimopoulou, Anastasia
    Dimopoulou, Dimitra
    Zavras, Nikolaos
    Fessatou, Smaragdi
    ARCHIVES DE PEDIATRIE, 2022, 29 (03): : 171 - 176